Anti-FSTL1/FRP 抗体 [EPR21933-155]
Anti-FSTL1/FRP antibody [EPR21933-155]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal FSTL1/FRP antibody. Suitable for IP, WB and reacts with Rat, Mouse, Human samples. Cited in 11 publications.
別名を表示する
FRP, FSTL1, Follistatin-related protein 1, Follistatin-like protein 1
- IP
Unknown
Immunoprecipitation - Anti-FSTL1/FRP antibody [EPR21933-155] (AB223287)
FSTL1/FRP was immunoprecipitated from 0.35 mg rat embryo lysate with ab223287 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab223287 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : Rat embryo lysate 10 μg (Input).
Lane 2 : ab223287 IP in rat embryo lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab223287 in rat embryo lysate (-).
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 minute.
The molecular mass observed is consistent with what has been described in the literature (PMID : 28574994).
All lanes:
Immunoprecipitation - Anti-FSTL1/FRP antibody [EPR21933-155] (ab223287)
Predicted band size: 35 kDa
Observed band size: 43-55 kDa
false
- WB
Unknown
Western blot - Anti-FSTL1/FRP antibody [EPR21933-155] (AB223287)
Blocking/diluting buffer and concentration : 5% NFDM/TBST.
Exposure times :
Lane 1 and 2 : 3 minutes;
Lane 3 : 15 seconds.
The molecular mass observed is consistent with what has been described in the literature (PMID : 27234440).
All lanes:
Western blot - Anti-FSTL1/FRP antibody [EPR21933-155] (ab223287) at 1/1000 dilution
Lane 1:
Human serum at 20 µg
Lane 2:
Mouse serum at 20 µg
Lane 3:
Rat serum at 20 µg
Secondary
Lanes 1 - 2:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Lane 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 35 kDa
Observed band size: 40-50 kDa
false
- WB
Lab
Western blot - Anti-FSTL1/FRP antibody [EPR21933-155] (AB223287)
Western blot : Anti-FSTL1/FRP antibody [EPR21933-155] ab223287 staining at 1/1000 dilution, shown in green; Mouse anti alpha Tubulin (ab7291) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 40 kDa in Wild-type HeLa cell lysates with no signal observed at this size in FSTL1 knockout HeLa cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-FSTL1/FRP antibody [EPR21933-155] (ab223287) at 1/1000 dilution
Lane 1:
Wild-type HeLa at 20 µg
Lane 2:
Human FSTL1 knockout HeLa cell line at 20 µg
Lane 3:
A431 at 20 µg
Lane 4:
Ramos at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 40 kDa
Observed band size: 40 kDa
false
- WB
Unknown
Western blot - Anti-FSTL1/FRP antibody [EPR21933-155] (AB223287)
Blocking/diluting buffer and concentration : 5% NFDM/TBST.
The molecular mass observed is consistent with what has been described in the literature (PMID : 28574994).
Negative control : Rat liver (PMID : 20861081).
All lanes:
Western blot - Anti-FSTL1/FRP antibody [EPR21933-155] (ab223287) at 1/1000 dilution
Lane 1:
Rat E14 embryo lysate at 20 µg
Lane 2:
Mouse E14 embryo lysate at 20 µg
Lane 3:
C6 (Rat glial tumor cell line) cell lysate at 20 µg
Lane 4:
Rat liver lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 35 kDa
Observed band size: 43-45 kDa
false
Exposure time: 48s
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FSTL1 serves as a modulator in inflammatory and developmental processes. It is a part of a complex that regulates immune responses and cell growth. The protein has been shown to affect the activity of multiple growth factors including Bone Morphogenetic Proteins (BMPs) revealing its regulatory capacity in tissue development and repair. FSTL1 can influence cell differentiation proliferation and survival highlighting its significance in maintaining cellular homeostasis.
Pathways
FSTL1 has important roles in the regulation of the BMP signaling and Wnt pathways. In the BMP pathway FSTL1 interacts with other signaling molecules to modulate pathway intensity and cellular outcomes. The protein links with BMP proteins to influence processes like bone formation and tissue repair. In the Wnt pathway FSTL1 can modulate key interactions that affect cellular proliferation and development. Through these pathways FSTL1 also relates to proteins such as TGF-beta which participate in various cellular processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (11)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:232 PubMed40011941
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular biology (Noisy-le-Grand, France) 69:137-142 PubMed38279459
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2206758 PubMed37282819
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical laboratory analysis 36:e24401 PubMed35373391
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 10:223 PubMed35280389
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:757068 PubMed34957094
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:7146-7156 PubMed34190406
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 20:914-926 PubMed33843447
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:8643-8664 PubMed33714952
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 16:e1009053 PubMed33270808
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com